Acetylation of human KLF5 at lysine 369 switches its transcriptional activity from a repressor to an activator for the p15 gene in the HaCaT epidermal epithelial cell line and prostate cancer cells [20, 28, 29]. This evidence concerns the gene CDKN2B and prostate carcinoma.